Add Yahoo as a preferred source to see more of our stories on Google. The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be ...

Add Yahoo as a preferred source to see more of our stories on Google. On Friday, Moderna’s mCombriax—a combined vaccine for both the flu and COVID—was recommended for authorization by European ...

The European Medicines Agency (EMA) has recommended granting marketing authorization to the combined influenza and COVID-19 messenger RNA (mRNA) vaccine, mCombriax (Moderna), for people aged 50 years ...

Vaccine effectiveness was generally higher in younger children younger than 8 years, at 63% in the 2023-2024 season, than ...

Feb 27 (Reuters) - Europe's medicines regulator recommended approval for Moderna's COVID and flu combination vaccine on Friday, putting it on track to become the ‌first single shot to protect people ...

Nurses in particular do not seem to be fans of the COVID-19 vaccine ...

More than three-quarters of American adults didn’t get a covid shot last season, a figure that health care experts warn could rise this year amid new U.S. government recommendations. As millions of ...

New Delhi: India’s apex drug regulator has approved the third phase of clinical trials for the country's first combined covid-19 and influenza vaccine from Serum Institute of India (SII), according to ...

CLEVELAND, Ohio — The respiratory virus season has just begun, and the best way to protect yourself is by getting immunized against flu, COVID-19 and respiratory syncytial virus or RSV. Updated ...

A single spritz could eventually offer simultaneous protection against several infectious diseases. Researchers at Stanford Medicine have developed a new vaccine that could prevent multiple viruses at ...

The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be granted market authorization in the European Union, marking the first time ...

This fall, a federal vaccine advisory panel changed recommendations, saying Americans six months and older should discuss the risks and benefits with their health care providers. The move walked back ...